Autosomal recessive agammaglobulinemia (ARA) is a primary immunodeficiency characterized by absent peripheral B cells, severe hypogammaglobulinemia, and absent BTK gene mutations. In ARA, mutations occur in genes encoding the pre-B cell receptor (pre-BCR) or downstream signaling proteins. In this work, we used candidate gene and whole-exome sequencing to investigate the molecular basis of ARA in 6 patients from 4 consanguineous North-African families. Sanger sequencing of candidate genes encoding the pre-BCR components (ΙGΗΜ, CD79A, CD79B, IGLL1, and VPREB1) was initially performed and determined the genetic defect in five patients. Two novel mutations in IGHM (p.Val378Alafs*1 and p.Ile184Serfs*21) were identified in three patients from two unrelated kindred and a novel nonsense mutation was identified in CD79A (p.Trp66*) in two siblings from a third kindred. Whole-exome sequencing (WES) was performed on the sixth patient who harbored a homozygous stop mutation at position 407 in the RAG2 gene (p.Glu407*). We concluded that conventional gene sequencing, especially when multiple genes are involved in the defect as is the case in ARA, is costly and time-consuming, resulting in delayed diagnosis that contributes to increased morbidity and mortality. In addition, it fails to identify the involvement of novel and unsuspected gene defects when the phenotype of the patients is atypical. WES has the potential to provide a rapid and more accurate genetic diagnosis in ARA, which is crucial for the treatment of the patients.
This is a preview of subscription content, log in to check access.
We acknowledge the patients and their families for their cooperation. We thank Dr. Michel J Massaad for the critical review of the manuscript.
This work was supported by the Tunisian Ministry of Higher Education and Research and the Institut Pasteur International Network (RIIP).
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
Karasuyama H, Nakamura T, Nagata K, Kuramochi T, Kitamura F, Kuida K. The roles of preB cell receptor in early B cell development and its signal transduction. Immunol Cell Biol. 1997;75(2):209–16.CrossRefGoogle Scholar
Conley ME, Broides A, Hernandez-Trujillo V, Howard V, Kanegane H, Miyawaki T, et al. Genetic analysis of patients with defects in early B-cell development. Immunol Rev. 2005;203:216–34.CrossRefGoogle Scholar
Berglöf A, Turunen JJ, Gissberg O, Bestas B, Blomberg KEM, Smith CIE. Agammaglobulinemia: causative mutations and their implications for novel therapies. Expert Rev Clin Immunol. 2013;9(12):1205–21.CrossRefGoogle Scholar
NaserEddin A, Shamriz O, Keller B, Alzyoud RM, Unger S, Fisch P, et al. Enteroviral Infection in a Patient with BLNK Adaptor Protein Deficiency. J Clin Immunol. 2015;35(4):356–60.CrossRefGoogle Scholar
Conley ME, Dobbs AK, Quintana AM, Bosompem A, Wang Y-D, Coustan-Smith E, et al. Agammaglobulinemia and absent B lineage cells in a patient lacking the p85α subunit of PI3K. J Exp Med. 2012;209(3):463–70.CrossRefGoogle Scholar
Boisson B, Wang Y-D, Bosompem A, Ma CS, Lim A, Kochetkov T, et al. A recurrent dominant negative E47 mutation causes agammaglobulinemia and BCR(-) B cells. J Clin Invest. 2013;123(11):4781–5.CrossRefGoogle Scholar
Ben-Ali M, Yang J, Chan KW, Ben-Mustapha I, Mekki N, Benabdesselem C, et al. Homozygous transcription factor 3 gene (TCF3) mutation is associated with severe hypogammaglobulinemia and B-cell acute lymphoblastic leukemia. J Allergy Clin Immunol. 2017;140(4):1191–1194.e4.CrossRefGoogle Scholar
Barbouche M-R, Galal N, Ben-Mustapha I, Jeddane L, Mellouli F, Ailal F, et al. Primary immunodeficiencies in highly consanguineous North African populations. Ann N Y Acad Sci. 2011;1238:42–52.CrossRefGoogle Scholar
Al-Herz W, Aldhekri H, Barbouche M-R, Rezaei N. Consanguinity and primary immunodeficiencies. Hum Hered. 2014;77(1-4):138–43.CrossRefGoogle Scholar
Barbouche M-R, Mekki N, Ben-Ali M, Ben-Mustapha I. Lessons from genetic studies of primary immunodeficiencies in a highly consanguineous population. Front Immunol. 2017;8:737.CrossRefGoogle Scholar
Hedayat M, Massaad MJ, Lee YN, Conley ME, Orange JS, Ohsumi TK, et al. Lessons in gene hunting: a RAG1 mutation presenting with agammaglobulinemia and absence of B cells. J Allergy Clin Immunol. 2014;134(4):983–985.e1.CrossRefGoogle Scholar
Seleman M, Hoyos-Bachiloglu R, Geha RS, Chou J. Uses of next-generation sequencing technologies for the diagnosis of primary immunodeficiencies. Front Immunol. 2017;8:847.CrossRefGoogle Scholar
Aadam Z, Kechout N, Barakat A, Chan K-W, Ben-Ali M, Ben-Mustapha I, et al. X-linked agammagobulinemia in a large series of North African patients: frequency, clinical features and novel BTK mutations. J Clin Immunol. 2016;36(3):187–94.CrossRefGoogle Scholar
Bossy D, Milili M, Zucman J, Thomas G, Fougereau M, Schiff C. Organization and expression of the lambda-like genes that contribute to the mu-psi light chain complex in human pre-B cells. Int Immunol. 1991;3(11):1081–90.CrossRefGoogle Scholar
Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinforma Oxf Engl. 2009;25(14):1754–60.CrossRefGoogle Scholar
McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297–303.CrossRefGoogle Scholar
Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164.CrossRefGoogle Scholar
Chan A, Cowan M, Puck JM, Cheng LE. TREC Newborn screening can identify patients with leaky SCID and may improve outcome. J Allergy Clin Immunol. 2013;131(2):AB231.Google Scholar
Conley ME, Dobbs AK, Farmer DM, Kilic S, Paris K, Grigoriadou S, et al. Primary B cell immunodeficiencies: comparisons and contrasts. Annu Rev Immunol. 2009;27:199–227.CrossRefGoogle Scholar
Conley ME, Howard V. Clinical findings leading to the diagnosis of X-linked agammaglobulinemia. J Pediatr. 2002;141(4):566–71.CrossRefGoogle Scholar
Ferrari S, Zuntini R, Lougaris V, Soresina A, Sourková V, Fiorini M, et al. Molecular analysis of the pre-BCR complex in a large cohort of patients affected by autosomal-recessive agammaglobulinemia. Genes Immun. 2007;8(4):325–33.CrossRefGoogle Scholar
Khalili A, Plebani A, Vitali M, Abolhassani H, Lougaris V, Mirminachi B, et al. Autosomal recessive agammaglobulinemia: a novel non-sense mutation in CD79a. J Clin Immunol. 2014;34(2):138–41.CrossRefGoogle Scholar
Abolhassani H, Vitali M, Lougaris V, Giliani S, Parvaneh N, Parvaneh L, et al. Cohort of Iranian patients with congenital agammaglobulinemia: mutation analysis and novel gene defects. Expert Rev Clin Immunol. 2016;12(4):479–86.CrossRefGoogle Scholar
Tirosh I, Yamazaki Y, Frugoni F, Ververs FA, Allenspach EJ, Zhang Y, et al. Recombination activity of human recombination-activating gene 2 (RAG2) mutations and correlation with clinical phenotype. J Allergy Clin Immunol. 2019;143(2):726–35.CrossRefGoogle Scholar
Abolhassani H, Wang N, Aghamohammadi A, Rezaei N, Lee YN, Frugoni F, et al. A hypomorphic recombination-activating gene 1 (RAG1) mutation resulting in a phenotype resembling common variable immunodeficiency. J Allergy Clin Immunol. 2014;134(6):1375–80.CrossRefGoogle Scholar
Buckley RH, Schiff RI, Schiff SE, Markert ML, Williams LW, Harville TO, et al. Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr. 1997;130(3):378–87.CrossRefGoogle Scholar
Geier CB, Piller A, Linder A, Sauerwein KMT, Eibl MM, Wolf HM. Leaky RAG deficiency in adult patients with impaired antibody production against bacterial polysaccharide antigens. PLoS One. 2015;10(7):e0133220.CrossRefGoogle Scholar
Schröder C, Baerlecken NT, Pannicke U, Dörk T, Witte T, Jacobs R, et al. Evaluation of RAG1 mutations in an adult with combined immunodeficiency and progressive multifocal leukoencephalopathy. Clin Immunol Orlando Fla. 2017;179:1–7.CrossRefGoogle Scholar